February 23, 2018February 23, 2018

Imbruvica Only Moderately Effective in Relapsed Follicular Lymphoma Patients, Phase 2 Trial Shows

News

Imbruvica (ibrutinib) is only moderately effective against tumors in patients with relapsed follicular lymphoma, and certain clinical and genetic factors may have an impact on patient response, according to results ... Read more

June 15, 2015September 4, 2015

Follow-up PET/CT Highly Sensitive For Patients With Non-Hodgkin Lymphoma

News

A recent study presented during the 2015 Annual Meeting of the Society of Nuclear Medicine and Molecular Imaging (SNMMI), determined that for aggressive cases of Non-Hodgkin lymphoma (NHL) post-treatment surveillance with ... Read more